91 related articles for article (PubMed ID: 31938309)
1. The role of fenhexamid on the proliferation of ovarian cancer BG-1 cells.
Fei A; Fu H; Jiang H; Wei L; Zhang H; Fei A; Zhang Y; Zou T; Gao S; Li L; Jiang H; Zhou M; Xing H; Huang Y
Int J Clin Exp Pathol; 2018; 11(4):2025-2031. PubMed ID: 31938309
[TBL] [Abstract][Full Text] [Related]
2. Effect of fenhexamid and cyprodinil on the expression of cell cycle- and metastasis-related genes via an estrogen receptor-dependent pathway in cellular and xenografted ovarian cancer models.
Go RE; Kim CW; Choi KC
Toxicol Appl Pharmacol; 2015 Nov; 289(1):48-57. PubMed ID: 26344002
[TBL] [Abstract][Full Text] [Related]
3. Benzophenone-1 stimulated the growth of BG-1 ovarian cancer cells by cell cycle regulation via an estrogen receptor alpha-mediated signaling pathway in cellular and xenograft mouse models.
Park MA; Hwang KA; Lee HR; Yi BR; Jeung EB; Choi KC
Toxicology; 2013 Mar; 305():41-8. PubMed ID: 23328252
[TBL] [Abstract][Full Text] [Related]
4. Genistein, a soy phytoestrogen, prevents the growth of BG-1 ovarian cancer cells induced by 17β-estradiol or bisphenol A via the inhibition of cell cycle progression.
Hwang KA; Kang NH; Yi BR; Lee HR; Park MA; Choi KC
Int J Oncol; 2013 Feb; 42(2):733-40. PubMed ID: 23229410
[TBL] [Abstract][Full Text] [Related]
5. Methoxychlor and triclosan stimulates ovarian cancer growth by regulating cell cycle- and apoptosis-related genes via an estrogen receptor-dependent pathway.
Kim JY; Yi BR; Go RE; Hwang KA; Nam KH; Choi KC
Environ Toxicol Pharmacol; 2014 May; 37(3):1264-74. PubMed ID: 24835555
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor α and insulin-like growth factor-1 receptor signaling pathways.
Hwang KA; Park MA; Kang NH; Yi BR; Hyun SH; Jeung EB; Choi KC
Toxicol Appl Pharmacol; 2013 Nov; 272(3):637-46. PubMed ID: 23933164
[TBL] [Abstract][Full Text] [Related]
7. Treatment of BG-1 Ovarian Cancer Cells Expressing Estrogen Receptors with Lambda-cyhalothrin and Cypermethrin Caused a Partial Estrogenicity Via an Estrogen Receptor-dependent Pathway.
Kim CW; Go RE; Choi KC
Toxicol Res; 2015 Dec; 31(4):331-7. PubMed ID: 26877835
[TBL] [Abstract][Full Text] [Related]
8. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
Kim YS; Choi KC; Hwang KA
Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
[TBL] [Abstract][Full Text] [Related]
9. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
10. BG-1 ovarian cell line: an alternative model for examining estrogen-dependent growth in vitro.
Baldwin WS; Curtis SW; Cauthen CA; Risinger JI; Korach KS; Barrett JC
In Vitro Cell Dev Biol Anim; 1998 Sep; 34(8):649-54. PubMed ID: 9769151
[TBL] [Abstract][Full Text] [Related]
11. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY
World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035
[TBL] [Abstract][Full Text] [Related]
12. Effect of benzophenone-1 and octylphenol on the regulation of epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in estrogen receptor expressing ovarian cancer cells.
Shin S; Go RE; Kim CW; Hwang KA; Nam KH; Choi KC
Food Chem Toxicol; 2016 Jul; 93():58-65. PubMed ID: 27145024
[TBL] [Abstract][Full Text] [Related]
13. Estrogen upregulation of BRCA1 expression with no effect on localization.
Romagnolo D; Annab LA; Thompson TE; Risinger JI; Terry LA; Barrett JC; Afshari CA
Mol Carcinog; 1998 Jun; 22(2):102-9. PubMed ID: 9655254
[TBL] [Abstract][Full Text] [Related]
14. The role of fenhexamid on the proliferation of ovarian cancer BG-1 cells [Retraction].
Int J Clin Exp Pathol; 2020; 13(3):634. PubMed ID: 32269705
[TBL] [Abstract][Full Text] [Related]
15. Bisphenol A and nonylphenol have the potential to stimulate the migration of ovarian cancer cells by inducing epithelial-mesenchymal transition via an estrogen receptor dependent pathway.
Kim YS; Hwang KA; Hyun SH; Nam KH; Lee CK; Choi KC
Chem Res Toxicol; 2015 Apr; 28(4):662-71. PubMed ID: 25690688
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
[TBL] [Abstract][Full Text] [Related]
17. Non-genomic effects of 17beta-estradiol in activation of the ERK1/ERK2 pathway induces cell proliferation through upregulation of cyclin D1 expression in bovine artery endothelial cells.
Fu XD; Cui YH; Lin GP; Wang TH
Gynecol Endocrinol; 2007 Mar; 23(3):131-7. PubMed ID: 17454165
[TBL] [Abstract][Full Text] [Related]
18. The growth response of BG-1 ovarian carcinoma cells to estradiol, 4OH-tamoxifen, and tamoxifen: evidence for intrinsic antiestrogen activation.
Pavlik EJ; Nelson K; van Nagell JR; Gallion HS; Donaldson ES; DePriest P; Meares K; van Nagell JR
Gynecol Oncol; 1991 Sep; 42(3):245-9. PubMed ID: 1955187
[TBL] [Abstract][Full Text] [Related]
19. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells.
Hall JM; Korach KS
Mol Endocrinol; 2003 May; 17(5):792-803. PubMed ID: 12586845
[TBL] [Abstract][Full Text] [Related]
20. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms.
Manole D; Schildknecht B; Gosnell B; Adams E; Derwahl M
J Clin Endocrinol Metab; 2001 Mar; 86(3):1072-7. PubMed ID: 11238488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
